Chronic Unilateral Lumbar Radicular Pain
ConditionNeuropathic Pain
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorAin Shams University
About this trial
Chronic neuropathic lumbar pain is among one of the most widespread complaints of patients.Many approaches have been attempted to target chronic pain, with varying efficacy and risks. Transgrade (TG) epidural injection is a new technique using a Racz- Coudé needle for epidural access at a "transgrade" angle without requiring any specialized hardware or accessories. Interlaminar (IL) epidural steroid injection (ESI) is one of the procedures that involves the delivery of injectate to the epidural space through directing a needle between the laminae of two adjacent vertebrae.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
> 6-month history of persistent pain in one leg with back pain.
Capable of giving informed consent.
Unsatisfactory response to conventional treatments including physical therapy or medications with a numeric rating scale (NRS) ≥ 5.
Disqualifiers
Previous lumbar spinal surgery.
Myelopathy.
Rheumatoid disorders.
Psychiatric disorders
Trial design
Design model
Parallel
Treatments tested in this trial
Transgrade technique (TG)
Other interventionTransgrade (TG) Epidural Steroid Injection technique
Interlaminar technique (IL)
Other interventionInterlaminar (IL) Epidural Steroid Injection technique
Treatment groups
80 Participants
are divided into 2 treatment groupsGroup A: Transgrade technique (TG)Active comparator 1 intervention
Group B: Interlaminar technique (IL)Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
Number of patients who experienced successful pain relief at 3 month post-intervention
Number of patients who experienced successful pain relief at 3 month post-intervention, which is defined as ≥ 50% reduction of numeric rating scale (NRS-11) from pre-intervention level.
Time frame
6 month post intervention (study period)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov